Asterias Biotherapeutics, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 10, 2015

Attached files

file filename
EX-31 - EXHIBIT 31 - Asterias Biotherapeutics, Inc.ex31.htm
EX-32 - EXHIBIT 32 - Asterias Biotherapeutics, Inc.ex32.htm
EX-23.2 - EXHIBIT 23.2 - Asterias Biotherapeutics, Inc.ex23_2.htm
EX-10.26 - EXHIBIT 10.26 - Asterias Biotherapeutics, Inc.ex10_26.htm
EX-10.25 - EXHIBIT 10.25 - Asterias Biotherapeutics, Inc.ex10_25.htm
EX-10.27 - EXHIBIT 10.27 - Asterias Biotherapeutics, Inc.ex10_27.htm
EXCEL - IDEA: XBRL DOCUMENT - Asterias Biotherapeutics, Inc.Financial_Report.xls
10-K - ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2014 - Asterias Biotherapeutics, Inc.form10k.htm
EXHIBIT 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-200745) and related prospectus of Asterias Biotherapeutics, Inc. (a company in the development stage) of our reports dated March 9, 2015 relating to the financial statements of Asterias Biotherapeutics, Inc. and the effectiveness of Asterias Biotherapeutic, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.

/s/ OUM & CO. LLP

San Francisco, California
March 9, 2015

 

Asterias Biotherapeutics, Inc. Reports